Ibrunat is a kinase inhibitor indicated for the treatment of patients with: • Mantle cell lymphoma (MCL) who have received at least one prior therapy. • Chronic lymphocytic leukemia (CLL) who have received at least one prior therapy. • Chronic lymphocytic leukemia with 17p deletion. • Waldenström’s macroglobulinemia.
IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.
For procurement cost of Ibrunat (Ibrutinib) brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the Ibrunat (Ibrutinib) medicine cost price in India.
The order for Ibrunat (Ibrutinib) will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Dacomitinib was approved in the United States in 2018, in Japan in 2019 and in the European Union (EU) authorized by the European Medicines Agency (EMA) in 2019 for the treatment of non-small cell lung cancer with EGFR gene mutation.
Ibrunat® (Ibrutinib) Tablets
Generic Name: Ibrutinib/p>
Capsule: 140 mg
IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Ibrunat (Ibrutinib) on prescription and Import License in Patient's Name only.
For overseas patients, Ibrunat (Ibrutinib) can be made available in Send your enquiry to find Ibrunat (Ibrutinib) in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
For Ibrunat (Ibrutinib) Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details